Studies show that CYP2D6 genotype does not predict tamoxifen benefit
Two studies published March 6 in the Journal of the National Cancer Institute provide insights about the CYP2D6 genotype in postmenopausal breast cancer patients and represent a major step forward in understanding the usefulness ...
Mar 6, 2012
0
0